Close Menu

University of Muenster

Researchers in the US and Europe are implementing pathogen sequencing surveillance programs to track infectious diseases within hospitals.

Several groups who have sequenced and analyzed the E. coli outbreak strain and related genomes disagree on the evolutionary path that led to the strain responsible for more than 50 deaths.

According to Dag Harmsen, director of research at the University of Münster, the quick turnaround time of the instrument made it possible to obtain results within three days. "The biggest advantage [of the PGM] from my point of view as a public health official is that it's speedy, and speed is what is needed at the moment," he told In Sequence.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.